Aetiology of pre-eclampsia and thrombophilic genetic mutations

Clinical Science

Volumn 105, Issue 3, 2003, Pages 269-271

  Hayashi, Masatoshi ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Factor V Leiden; G20210A prothrombin mutation; HELLP syndrome; PCR; Pregnancy complication; Thrombophilic mutation

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

FETOMATERNAL TRANSFUSION; GENE MUTATION; HELLP SYNDROME; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

FACTOR V; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; HELLP SYNDROME; HUMANS; INFANT, NEWBORN; MUTATION; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROTHROMBIN; THROMBOSIS;

EID: 0041875074     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030181     Document Type: Review

References (24)

1. Girling, J. and de Swiet, M. (1998) Inherited thrombophilia and pregnancy. Curr. Opin. Obstet. Gynecol. 10, 135-144
2. Dizon-Townson, D. S., Nelson, L. M., Easton, K. and Ward, K. (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am. J. Obstet. Gynecol. 175, 902-905
3. Kupferminc, M. J., Eldor, A., Steinman, N. et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med. 340, 9-13
4. Roberts, J. M. and Cooper, D. W. (2001) Pathogenesis and generics of pre-eclampsia. Lancet 357, 53-56
5. Dekker, G. A. and Sibai, B. M. (1998) Etiology and pathogenesis of preeclampsia: current concepts. Am. J. Obstet. Gynecol. 179, 1359-1375
6. Livingston, J. C., Barton, J. R., Park, V., Haddad, B., Phillips, O. and Sibai, B. M. (2001) Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am. J. Obstet. Gynecol. 185, 153-157
7. Morrison, E. R., Miedzybrodzka, Z. H., Campbell, D. M. et al. (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb. Haemostasis 87, 779-785
8. von Dadelszen, P., Wilkins, T. and Redman, C. W. (1999) Maternal peripheral blood leukocytes in normal and pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 106, 576-581
9. Sacks, G. P., Studena, K., Sargent K. and Redman, C. W. (1999) Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol. 180, 1310-1311
10. von Dadelszen, P., Hurst, G. and Redman, C. W. (1999) Supernatants from co-cultured endothelial cells and syncytiotrophoblast microvillous membranes activate peripheral blood leukocytes in vitro. Hum. Reprod. 14, 919-924
11. Redman, C. W., Sacks, G. P. and Sargent, I. L. (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am. J. Obstet. Gynecol. 180, 499-506
12. Hayashi, M., Numaguchi, M., Watabe, H. and Yaoi, Y. (1996) High blood levels of macrophage colony-stimulating factor in preeclampsia. Blood 88, 4426-4428
13. Hayashi, M. and Ohkura, T. (2002) Elevated levels of serum macrophage colony-stimulating factor in normotensive pregnancies complicated by intrauterine fetal growth restriction. Exp. Hematol. 38, 388-393
14. Hayashi, M., Hoshimoto, K., Ohkura, T. and Inaba, N. (2002) Increased levels of macrophage colony-stimulating factor in the placenta and blood in preeclampsia. Am. J. Reprod. Immunol. 47, 19-24
15. Hayashi, M., Ohkura, T. and Inaba, N. (2003) Elevation of serum macrophage colony-stimulating factor before the clinical manifestations of preeclampsia. Am. J. Obstet. Gynecol., in the press
16. Sunder-Plassmann, G., Derfler, K., Wagner, L. et al. (1989) Increased serum activity of interleukin-2 in patients with pre-eclampsia. J. Autoimmun. 2, 203-205
17. Daniel, Y., Kupferminc, M. J., Baram, A. et al. (1998) Plasma interleukin-12 is elevated in patients with preeclampsia. Am. J. Reprod. Immunol. 39, 376-380
18. Hamai, Y., Fujii, T., Yamashita, T. et al. (1997) Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am. J. Reprod. Immunol. 38, 89-93
19. Rees, D. C., Cox, M. and Clegg, J. B. (1995) World distribution of factor V Leiden. Lancet 346, 1133-1134
20. Ehrenforth, S., Radtke, K. P. and Scharrer, I. (1995) Acquired activated protein C-resistance in patients with lupus anticoagulants. Thromb. Haemostasis 74, 797-798
21. Borrell, M., Sala, N., de Castellarnau, C., Lopez, S., Gari, M. and Fontcuberta, J. (1992) Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells. Thromb. Haemostasis 68, 268-272
22. Poort, S. R., Rosendaal, F. R., Reitsma, P. H. and Bertina, R. M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698-3703
23. Gerhardt, A., Scharf, R. E., Beckmann, M. W. et al. (2000) Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N. Engl. J. Med. 342, 374-380
24. Schlembach, D., Beinder, E., Zingsem, J., Wunsiedler, U., Beckmann, M. W. and Fischer, T. (2003) Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin. Sci. 105, 279-285